Clinical Trial Update: Determining the Tolerance of Depigmented Skin to Targeted Phototherapy Using UVB in Patients With Vitiligo [NA]

View source ↗

Summary

This clinical trial update reports completed results for assessing how depigmented skin in vitiligo patients tolerates UVB-targeted phototherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Snippet

Sponsor: Henry Ford Health System | Conditions: Vitiligo | NA | Status: COMPLETED